Home / Inspections / 1231003

FDA Inspection 1231003 — BASF Corporation

BASF Corporation — FEI 2316568

The FDA completed an inspection of BASF Corporation on July 22, 2024 in Geismar, LA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 22, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Geismar, LA (United States)

Facility

Other inspections at this facility

  • 1130587 (NAI Thu Sep 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1070220 (NAI Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 980496 (NAI Thu Jul 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 866852 (NAI Thu Feb 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources